Bavarian Nordic shares rise 7% following strong Q1 for vaccine sales

Bavarian Nordic is successfully navigating a sentiment-changing vaccine landscape, posting Q1 revenues significantly up from Q1 2024.

May 10, 2025 - 06:00

Bavarian Nordic shares rise 7% following strong Q1 for vaccine sales

Bavarian Nordic is successfully navigating a sentiment-changing vaccine landscape, posting Q1 revenues significantly up from Q1 2024.

Read the original article

Tags:

Previous Article

HLS Therapeutics and Esperion partner to commercialise oral cardiovascular medic...

NewBiologix licenses cell line technology to Recipharm Advanced Bio

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Studies highlight risks of excluding people with obesity from drug trials

Studies highlight risks of excluding people with obesit...

Oct 16, 2023

STAT+: ‘Like playing the lottery’: A mixed picture for laid-off life sciences workers in Massachusetts

STAT+: ‘Like playing the lottery’: A mixed picture for ...

Oct 10, 2023

Ketamine is comparable to ECT for patients with treatment-resistant depression, study shows

Ketamine is comparable to ECT for patients with treatme...

May 25, 2023